Literature DB >> 12505541

Kynurenines and the respiratory parameters on rat heart mitochondria.

H Baran1, K Staniek, B Kepplinger, J Stur, M Draxler, H Nohl.   

Abstract

It has been shown recently that the L-kynurenine metabolite kynurenic acid lowers the efficacy of mitochondria ATP synthesis by significantly increasing state IV, and reducing respiratory control index and ADP/oxygen ratio of glutamate/malate-consuming heart mitochondria. In the present study we investigated the effect of L-tryptophan (1.25 microM to 5 mM) and other metabolites of L-kynurenine as 3-hydroxykynurenine (1.25 microM to 2.5 mM), anthranilic acid (1.25 microM to 5 mM) and 3-hydroxyanthranilic acid (1.25 microM to 5 mM) on the heart mitochondria function. Mitochondria were incubated with saturating concentrations of respiratory substrates glutamate/malate (5 mM), succinate (10 mM) or NADH (1 mM) in the presence or absence of L-tryptophan metabolites. Among tested substances, 3-hydroxykynurenine, 3-hydroxyanthranilic acid and anthranilic acid but not tryptophan affected the respiratory parameters dose-dependently, however at a high concentration, of a micro molar range. 3-Hydroxykynurenine and 3-hydroxyanthranilic acid lowered respiratory control index and ADP/oxygen ratio in the presence of glutamate/malate and succinate but not with NADH. While, anthranilic acid reduced state III oxygen consumption rate and lowered the respiratory control index only of glutamate/malate-consuming heart mitochondria. Co-application of anthranilic acid and kynurenic acid (125 or 625 microM each) to glutamate/malate-consuming heart mitochondria caused a non-additive deterioration of the respiratory parameters determined predominantly by kynurenic acid. Accumulated data indicate that within L-tryptophan metabolites kynurenic acid is the most effective, followed by anthranilic acid, 3-hydroxykynurenine, 3-hydroxyanthranilic acid to influence the respiratory parameters of heart mitochondria. Present data allow to speculate that changes of kynurenic acid and/or anthranilic acid formation in heart tissue mitochondria due to fluctuation of L-kynurenine metabolism may be of functional importance for cardiovascular processes. On the other hand, beside the effect of 3-hydroxyanthranilic acid and 3-hydroxykynurenine on respiratory parameters, their oxidative reactivity may contribute to impairment of mitochondria function, too.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505541     DOI: 10.1016/s0024-3205(02)02365-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

Review 1.  Cardiovascular redox and ox stress proteomics.

Authors:  Vikas Kumar; Timothy Dean Calamaras; Dagmar Haeussler; Wilson Steven Colucci; Richard Alan Cohen; Mark Errol McComb; David Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

2.  Anthranilic acid-uraemic toxin damaged red cell's membrane.

Authors:  A Tankiewicz; D Pawlak; K Pawlak; D Szewc; M Myśliwiec; W Buczko
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity.

Authors:  Trace Thome; Zachary R Salyers; Ravi A Kumar; Dongwoo Hahn; Fabian N Berru; Leonardo F Ferreira; Salvatore T Scali; Terence E Ryan
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-10       Impact factor: 4.249

4.  Kynurenines impair energy metabolism in rat cerebral cortex.

Authors:  Patrícia Fernanda Schuck; Anelise Tonin; Gustavo da Costa Ferreira; Carolina Maso Viegas; Alexandra Latini; Clovis Milton Duval Wannmacher; Angela Terezinha de Souza Wyse; Carlos Severo Dutra-Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2006-12-07       Impact factor: 5.046

5.  Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents.

Authors:  S E McCormack; O Shaham; M A McCarthy; A A Deik; T J Wang; R E Gerszten; C B Clish; V K Mootha; S K Grinspoon; A Fleischman
Journal:  Pediatr Obes       Date:  2012-09-07       Impact factor: 4.000

6.  Endogenous Kynurenine Aminotransferases Inhibitor is Proposed to Act as "Glia Depressing Factor" (GDF).

Authors:  Halina Baran; Berthold Kepplinger; Markus Draxler
Journal:  Int J Tryptophan Res       Date:  2010-05-11

7.  Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease.

Authors:  Trace Thome; Ravi A Kumar; Sarah K Burke; Ram B Khattri; Zachary R Salyers; Rachel C Kelley; Madeline D Coleman; Demetra D Christou; Russell T Hepple; Salvatore T Scali; Leonardo F Ferreira; Terence E Ryan
Journal:  JCI Insight       Date:  2020-12-08

8.  Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients.

Authors:  H Baran; J A Hainfellner; B Kepplinger
Journal:  Int J Tryptophan Res       Date:  2012-12-13

Review 9.  Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases.

Authors:  Jazmin Reyes Ocampo; Rafael Lugo Huitrón; Dinora González-Esquivel; Perla Ugalde-Muñiz; Anabel Jiménez-Anguiano; Benjamín Pineda; José Pedraza-Chaverri; Camilo Ríos; Verónica Pérez de la Cruz
Journal:  Oxid Med Cell Longev       Date:  2014-02-17       Impact factor: 6.543

10.  Effects of Various Kynurenine Metabolites on Respiratory Parameters of Rat Brain, Liver and Heart Mitochondria.

Authors:  Halina Baran; Katrin Staniek; Melanie Bertignol-Spörr; Martin Attam; Carina Kronsteiner; Berthold Kepplinger
Journal:  Int J Tryptophan Res       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.